These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
958 related articles for article (PubMed ID: 11162134)
1. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134 [TBL] [Abstract][Full Text] [Related]
2. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Su H; Lu R; Kan YW Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis for ischemic syndromes. Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418 [TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs. Chen F; Tan Z; Dong CY; Chen X; Guo SF Acta Pharmacol Sin; 2007 Apr; 28(4):493-502. PubMed ID: 17376288 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo study of the expression vector encoding vascular endothelial growth factor. Malecki M; Przybyszewska M; Janik P Arch Immunol Ther Exp (Warsz); 2001; 49(3):243-6. PubMed ID: 11478399 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248 [TBL] [Abstract][Full Text] [Related]
7. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor. Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920 [TBL] [Abstract][Full Text] [Related]
8. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor]. Zaric V; Weltin D; Stephan D Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743 [TBL] [Abstract][Full Text] [Related]
11. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases. Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037 [TBL] [Abstract][Full Text] [Related]
12. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization. Chen F; Tan Z; Dong CY; Li X; Xie Y; Wu Y; Chen X; Guo S Eur J Pharmacol; 2007 Jul; 568(1-3):222-30. PubMed ID: 17553485 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Saleh M; Stacker SA; Wilks AF Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597 [TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus vectors for vascular gene delivery. Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972 [TBL] [Abstract][Full Text] [Related]
17. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562 [TBL] [Abstract][Full Text] [Related]
18. [The in vivo and in vitro effects on neovascularization of VEGF gene transfer with a new pseudotyped rAAV1 vector]. Yan H; Wu XB; Guo YH; Zhang P; Chen L; Dong XY; Wang GS; Gao W Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):69-73. PubMed ID: 17386170 [TBL] [Abstract][Full Text] [Related]
19. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065 [TBL] [Abstract][Full Text] [Related]